The Journal of Urology
Volume 183, Issue 4 , Pages 1432-1437, April 2010

Under Treatment of Overactive Bladder Symptoms in Patients With Multiple Sclerosis: An Ancillary Analysis of the NARCOMS Patient Registry

  • S.T. Mahajan

      Affiliations

    • Department of Obstetrics and Gynecology and Urology, University Hospitals Case Medical Center, Cleveland, Ohio
    • Corresponding Author InformationCorrespondence: 11100 Euclid Ave., MAC 5034, Cleveland, Ohio 44106 (telephone: 216-844-4906; FAX: 216-844-5167)
    • Financial interest and/or other relationship with Pfizer, Inc. and Duramed.
  • ,
  • P.B. Patel

      Affiliations

    • Department of Obstetrics and Gynecology and Urology, University Hospitals Case Medical Center, Cleveland, Ohio
  • ,
  • R.A. Marrie

      Affiliations

    • Internal Medicine and Community Health Sciences, University of Manitoba, Winnipeg, Manitoba, Canada

Received 13 August 2009 published online 22 February 2010.

Purpose

We describe the prevalence of overactive bladder symptoms in patients with multiple sclerosis as well as the rates of evaluation and treatment of urinary complaints.

Materials and Methods

Data from the fall 2005 North American Research Committee On Multiple Sclerosis survey were examined, including the Urogenital Distress Inventory plus a nocturia question, the SF-12, and inquiries regarding urological care and treatments. Data were analyzed using descriptive statistics, chi-square and Student's t tests, ANOVA and multivariable logistic regression.

Results

Of 16,858 surveys distributed 9,702 (58%) were completed. Participants with a surgically altered bladder were excluded from analysis (21). At least 1 moderate to severe urinary symptom (score of 2 or greater) was reported by 6,263 (65%) respondents. Increasing overactive bladder symptoms were correlated with longer disease duration (r = 0.135) and increasing physical disability (r = 0.291) (both p <0.001). Decreased quality of life was associated with increasing disability (p <0.001) and overactive bladder symptom score (p <0.001). Of patients with moderate to severe overactive bladder symptoms only 2,710 (43.3%) were evaluated by urology and 2,361 (51%) were treated with an anticholinergic medication. Treated patients more frequently reported leakage (p <0.001) and newer treatments were significantly underused (less than 10% total use). Catheter use was reported by 2,309 (36.8%) respondents, and was associated with greater disability, higher overactive bladder symptom score and reduced quality of life (all p <0.001).

Conclusions

This large scale study identified high rates of overactive bladder symptoms in patients with MS, and correlations with increasing disease duration and physical disability. Despite an increasing awareness of overactive bladder symptoms and the need for evaluation and treatment, many patients remain underserved.

Key Words: urinary bladder, overactive, multiple sclerosis, urinary incontinence, urge

Abbreviations and Acronyms: ISC, intermittent self-catheterization, MCS-12, Mental Component Score, MS, multiple sclerosis, NARCOMS, North American Research Committee On Multiple Sclerosis, OAB, overactive bladder, PCS-12, Physical Component Score, PDDS, Patient Determined Disease Steps, QOL, quality of life, SF-12, Medical Outcomes Study Short Form-12, SF-36, Medical Outcomes Study Short Form-36, SPC, suprapubic catheterization, TFC, transurethral Foley catheter, UDI-6, Urogenital Distress Inventory-Short Form

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 30.00 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

 See Editorial on page 1282.

PII: S0022-5347(09)03193-0

doi:10.1016/j.juro.2009.12.029

Refers to article:

  • Under Treatment of Overactive Bladder , 19 February 2010

    Katie N. Ballert
    The Journal of Urology April 2010 (Vol. 183, Issue 4, Pages 1282-1283)

The Journal of Urology
Volume 183, Issue 4 , Pages 1432-1437, April 2010